Home Front
United States Patent Number 5,988,870
[spacer size=”80″]
[grid]
[col size=”1-3″ icon=”info-circle”]
Rhinitis Medicamentosa
Rhinitis Medicamentosa (RM) is a form of chemically induced nasal congestion associated with the use of topical decongestant nasal sprays. The challenge in treating RM patients is the severe congestion which can persist for 4-7 days after the sprays are abruptly withdrawn. Rhinostat allows RM patients to maintain normal nasal airflow as they are gradually weaned from the decongestant nasal sprays.
Learn more about Rhinitis Medicamentosa
[/col]
[col size=”1-3″ icon=”info-circle”]
The Rhinostat System
The cornerstone of treating RM is always the same; patients must discontinue their use of the decongestant sprays. Very few patients are capable of tolerating the restricted nasal airflow associated with conventional protocols, which is why the treatment of RM patients often fails. To preserve normal airflow, Rhinostat users wean themselves in a precise and gradual manner over a 3-5 week period (taper titration.)
[/col]
[col size=”1-3″ icon=”info-circle”]
Safe, Effective, Guaranteed
Rhinostat is the Rhinitis Medicamentosa Company. Helping RM patients is our only business since 1999. We work directly with RM patients as well as their physician’s office. No prescription is required, and Rhinostat offers an unconditional 100% money back guarantee. We ship to more than 70 countries worldwide via the US Postal Service. Orders are discretely packaged and ship within one business day.
Ordering & Shipping Information
[/col]
[/grid]
[spacer size=”80″]
[grid align=”center”]
[col size=”2-3″ float=”right”]
Rhinostat has been in business since 1999.
We are proud to be an A+ Rated Member of the Florida Better Business Bureau.
Helping RM patients is our one and only business.
[/col]
[col size=”1-3″]
[/col]
[/grid]